JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB31967

Anti-PACT (PKR activating protein) / PRKRA antibody

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Polyclonal PACT (PKR activating protein) / PRKRA antibody. Suitable for ICC/IF, IP, WB and reacts with Human, Mouse, Rat samples. Cited in 6 publications.

View Alternative Names

PACT, RAX, HSD-14, HSD14, PRKRA, Interferon-inducible double-stranded RNA-dependent protein kinase activator A, PKR-associated protein X, PKR-associating protein X, Protein activator of the interferon-induced protein kinase

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

ab31967 staining PACT (PKR activating protein) / PRKRA in Hek293 cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab31967 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in green) and ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • WB

Project1883****

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

All lanes:

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (ab31967) at 1 µg/mL

Lane 1:

Testis (Mouse) Tissue Lysate - normal tissue at 10 µg

Lane 2:

PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

Predicted band size: 34 kDa

Observed band size: 34 kDa,55 kDa

false

Immunoprecipitation - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • IP

Unknown

Immunoprecipitation - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

PACT (PKR activating protein) / PRKRA was immunoprecipitated using 0.5mg Mouse Testis tissue, 5µg of Rabbit polyclonal to PACT (PKR activating protein) / PRKRA and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Mouse Testis tissue lysate lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab31967.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 34kDa; PACT (PKR activating protein) / PRKRA

All lanes:

Immunoprecipitation - Anti-PACT (PKR activating protein) / PRKRA antibody (ab31967)

Predicted band size: 34 kDa

false

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • WB

Project1883****

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

All lanes:

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (ab31967) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg with Human PACT (PKR activating protein) / PRKRA peptide (<a href='/en-us/products/unavailable/human-pact-pkr-activating-protein-prkra-peptide-ab30768'>ab30768</a>)

Secondary

All lanes:

IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution

Predicted band size: 34 kDa

Observed band size: 34 kDa,60 kDa

false

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • WB

Lab

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : PACT (PKR activating protein)/PRKRA knockout HAP1 cell lysate (20 μg)
Lane 3 : K562 cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab31967 observed at 36 kDa. Red - loading control, ab18058, observed at 124 kDa.

ab31967 was shown to recognize PACT (PKR activating protein)/PRKRA when PACT (PKR activating protein)/PRKRA knockout samples were used, along with additional cross-reactive bands. Wild-type and PACT (PKR activating protein)/PRKRA knockout samples were subjected to SDS-PAGE. ab31967 and ab18058 (loading control to Vinculin) were diluted at 1 μg/ml and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (ab31967)

Predicted band size: 34 kDa

false

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)
  • WB

Unknown

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (AB31967)

Lanes 1-4 : Merged signal (red and green). Green - ab31967 observed at 36 kDa. Red - loading control ab8245 observed at 36 kDa.

ab31967 Anti-PACT (PKR activating protein) / PRKRA antibody was shown to specifically react with PACT in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266806 (knockout cell lysate ab258141) was used. Wild-type and PACT knockout samples were subjected to SDS-PAGE. ab31967 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PACT (PKR activating protein) / PRKRA antibody (ab31967) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

PRKRA knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human PRKRA (PACT) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-prkra-pact-knockout-hek-293t-cell-line-ab266806'>ab266806</a>)

Lane 3:

K-562 cell lysate at 20 µg

Lane 4:

HepG2 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 34 kDa

Observed band size: 36 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Cow": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PACT also known as PKR activating protein or PRKRA is a regulator of the protein kinase R (PKR). This protein plays a role in PKR activation stimulating its autophosphorylation. Structurally PACT has a molecular mass of approximately 37 kDa. Researchers observed its expression in many tissues with notable presence in the brain and in immune cells. PACT functions interact with PKR and it also goes by the alternative names PKR activator and PKR protein activator.
Biological function summary

PACT involves in the cellular stress response signaling. It serves as an activator for PKR a kinase that becomes active during viral infections and stress. PACT forms complexes with PKR facilitating its activation and subsequent initiation of downstream signaling cascades. It contributes significantly to the regulation of protein synthesis and cell growth by modulating these pathways. In conditions of stress PACT ensures adequate PKR activation for host defense.

Pathways

PACT is key in the interferon signaling pathway and the stress response pathway. It partners with PKR to suppress protein synthesis through phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2α) which slows down protein production during cellular stress. This interaction places PACT at a junction of antiviral defense and stress adaptation with PKR serving as an essential protein involved in these pathways.

PACT links to conditions such as Huntington’s disease and dystonia. Dysregulation in PACT's function impacts these neurodegenerative disorders as it relates to its role in stress response. Altered interactions between PACT and PKR contribute to neuronal dysfunction highlighting its importance in these pathologies. Understanding how PACT and its partner proteins like PKR and eIF2α operate can lead to potential therapeutic targets for these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53 association and sumoylation and phosphorylation of p53/TP53 at 'Lys-386' at 'Ser-392' respectively and enhances its activity in a EIF2AK2/PKR-dependent manner (By similarity).
See full target information PRKRA

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

PLoS genetics 19:e1010797 PubMed37307272

2023

Retrotransposon LINE-1 bodies in the cytoplasm of piRNA-deficient mouse spermatocytes: Ribonucleoproteins overcoming the integrated stress response.

Applications

Unspecified application

Species

Unspecified reactive species

Chiara De Luca,Anuj Gupta,Alex Bortvin

Communications biology 5:822 PubMed35970927

2022

Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.

Applications

Unspecified application

Species

Unspecified reactive species

Liuqing Yang,Kequan Lin,Lin Zhu,Huili Wang,Shuaishuai Teng,Lijun Huang,Shiyi Zhou,Guanbin Zhang,Zhi John Lu,Dong Wang

RNA biology 16:1263-1274 PubMed31135270

2019

A novel antisense RNA ASPACT confers multi-level suppression of PACT and associated signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Ping Kuo,Chung-Pei Ma,Hui-Wen Chen,Yi-Tung Chen,Yi-Hsuan Lai,Hsuan Liu,Rei-Lin Kuo,Bertrand Chin-Ming Tan

Journal of immunology (Baltimore, Md. : 1950) 199:1846-1855 PubMed28760879

2017

PACT Facilitates RNA-Induced Activation of MDA5 by Promoting MDA5 Oligomerization.

Applications

Unspecified application

Species

Unspecified reactive species

Pak-Yin Lui,Lok-Yin Roy Wong,Ting-Hin Ho,Shannon Wing Ngor Au,Chi-Ping Chan,Kin-Hang Kok,Dong-Yan Jin

Nucleic acids research 44:9942-9955 PubMed27407113

2016

S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells.

Applications

WB

Species

Human

Matthew J Warner,Katherine S Bridge,James P Hewitson,Michael R Hodgkinson,Alex Heyam,Bailey C Massa,Jessica C Haslam,Maria Chatzifrangkeskou,Gareth J O Evans,Michael J Plevin,Tyson V Sharp,Dimitris Lagos

PloS one 6:e18225 PubMed21464971

2011

Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.

Applications

WB

Species

Human

Adam K Wheatley,Marit Kramski,Marina R Alexander,Jesse G Toe,Rob J Center,Damian F J Purcell
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com